Single peptide Vial strength 5 mg
Cagrilintide5 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Cagrilintide, explained simply
A long-acting amylin analogue. Amylin helps regulate satiety, making this compound relevant to appetite and weight research.
Research area
Appetite and weight regulation
How it works
Activates amylin receptors, contributing to satiety signals and slower gastric emptying.
Why it matters
It is being studied alone and alongside medicines acting through other appetite pathways.
What has been observed
Phase 2 and phase 3 clinical studies have reported dose-dependent weight reductions.
Effects and points to consider
Nausea and other gastrointestinal symptoms are the most commonly reported effects in the cited studies. Findings come from specific investigational formulations and protocols.
01 / Vial strength 5 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 5 mg Cagrilintide |
|---|---|
| Final volume | 3 mL |
| Concentration | 1.67 mg/mL |
| One U-100 unit | 16.67 mcg in 0.01 mL |
Standard / Gradual Approach (3 mL = ~1.67 mg/mL)
| Week/Phase | Weekly Dose (mg) | Units (per injection) | Volume (mL) |
|---|---|---|---|
| Weeks 1–2 | 0.6 mg | 36 units | 0.36 mL |
| Weeks 3–4 | 1.2 mg | 72 units | 0.72 mL |
| Weeks 5–6 | 2.4 mg | 144 units | 1.44 mL |
| Weeks 7–16 (Maintenance) | 4.5 mg | 270 units | 2.70 mL |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.